Sarepta Therapeutics (SRPT) Construction in Progress (2013)
Sarepta Therapeutics' quarterly Construction in Progress came in at $11.3 million in Q4 2013.
Sarepta Therapeutics has reported Construction in Progress for 1 years, with the latest figure at $11.3 million in Q4 2013.
- For the quarter ending Q4 2013, Construction in Progress changed N/A year-over-year to $11.3 million; the trailing twelve-month figure through Dec 2013 stood at $11.3 million (changed N/A YoY), and the FY2013 full-year result was $11.3 million, changed N/A from the prior year.
- Construction in Progress for Q4 2013 stood at $11.3 million.
- The five-year high for Construction in Progress was $11.3 million in Q4 2013, with the low at $11.3 million in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 11.30 Mn |